We are live on ! Find out more
MC

Maverick Capital Portfolio holdings

AUM $8.67B
1-Year Est. Return 48.76%
This Fund
S&P 500
This Quarter Est. Return
+23.86%
1 Year Est. Return
+48.76%
3 Year Est. Return
+198.74%
5 Year Est. Return
+110.99%
10 Year Est. Return
+397.6%
AUM
$6.66B
AUM Growth
+$1B
Cap. Flow
-$23.9M
Cap. Flow %
-0.36%
Top 10 Hldgs %
47.38%
Holding
316
New
81
Increased
38
Reduced
44
Closed
65

Sector Composition

Rank Sector Weight
1 Technology 29.01%
2 Consumer Discretionary 18.97%
3 Healthcare 15.83%
4 Financials 11.93%
5 Consumer Staples 8.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WBD icon
26
Warner Bros
WBD
$64.6B
$77.9M 1.17%
+6,797,230
New +$63.4M
DHR icon
27
Danaher
DHR
$135B
$73.5M 1.1%
372,126
-326,614
-47% -$63.3M
TEVA icon
28
Teva Pharmaceuticals
TEVA
$35.9B
$73.4M 1.1%
4,377,690
+4,347,398
+14,352% +$70.2M
PRMB
29
Primo Brands
PRMB
$8.24B
$72M 1.08%
2,431,869
+491,794
+25% +$15.7M
UNH icon
30
UnitedHealth
UNH
$382B
$70.6M 1.06%
226,153
+79,235
+54% +$30.3M
DDOG icon
31
Datadog
DDOG
$87.9B
$69.3M 1.04%
+516,079
New +$57.1M
SGI
32
Somnigroup International
SGI
$15.1B
$67.7M 1.02%
994,560
-46,058
-4% -$2.9M
CPNG icon
33
Coupang
CPNG
$27.8B
$63M 0.95%
2,102,777
-76,418
-4% -$1.96M
ACHC icon
34
Acadia Healthcare
ACHC
$3.17B
$57.9M 0.87%
2,553,237
+306,314
+14% +$7.26M
GAP
35
The Gap Inc
GAP
$6.84B
$54.6M 0.82%
2,502,118
-259,778
-9% -$5.81M
LULU icon
36
lululemon athletica
LULU
$13B
$54M 0.81%
227,110
-145,195
-39% -$40M
WVE icon
37
Wave Life Sciences
WVE
$1.12B
$53.7M 0.81%
8,261,683
VRNA
38
DELISTED
Verona Pharma
VRNA
$49.4M 0.74%
521,859
-1,261,639
-71% -$93.4M
LLY icon
39
Eli Lilly
LLY
$1.07T
$45.9M 0.69%
+58,901
New +$45.8M
EVR icon
40
Evercore
EVR
$13.1B
$45.8M 0.69%
+169,745
New +$37.3M
MELI icon
41
Mercado Libre
MELI
$91.3B
$45.7M 0.69%
17,492
-1,432
-8% -$3.34M
CRWV
42
CoreWeave
CRWV
$39.2B
$43.7M 0.66%
267,740
-594,076
-69% -$54.8M
PCVX icon
43
Vaxcyte
PCVX
$7.89B
$42.6M 0.64%
1,310,605
+102,512
+8% +$3.36M
RBLX icon
44
Roblox
RBLX
$34B
$41.5M 0.62%
+394,875
New +$31M
LPLA icon
45
LPL Financial
LPLA
$26.3B
$37.3M 0.56%
99,507
-221,273
-69% -$77.5M
VRDN icon
46
Viridian Therapeutics
VRDN
$2.13B
$31.6M 0.47%
2,257,010
+195,736
+9% +$2.66M
NAMS icon
47
NewAmsterdam Pharma
NAMS
$3.47B
$27.7M 0.42%
1,531,874
+982,405
+179% +$17.9M
SAIL
48
SailPoint Inc
SAIL
$8.48B
$22.1M 0.33%
966,050
RCKT icon
49
Rocket Pharmaceuticals
RCKT
$348M
$20.5M 0.31%
8,363,813
+3,164,595
+61% +$16M
EVH icon
50
Evolent Health
EVH
$475M
$15.7M 0.24%
+1,392,524
New +$12.8M

Similar funds

Maverick Capital's Q2 2025 Portfolio in Review

As of Q2 2025, Maverick Capital held 316 positions worth $6.66B, up 18% from $5.66B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Maverick Capital's Q2 2025 filing shows 81 new, 38 increased, 44 reduced and 65 closed positions. Its largest new stake was Walt Disney: 1,508,487 shares worth $187M. The largest sale was Charles Schwab, an estimated $112M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Maverick Capital's largest Q2 2025 buy was Walt Disney: 1,508,487 shares worth $187M.
  • Maverick Capital added most to Microsoft in Q2 2025, an estimated $146M increase.
  • Maverick Capital's biggest Q2 2025 reduction was Verona Pharma, cutting an estimated $93.4M.
  • Maverick Capital fully exited Charles Schwab in Q2 2025, selling an estimated $112M.
  • Maverick Capital's ten largest holdings make up 47% of its $6.66B portfolio in Q2 2025.
  • Maverick Capital opened 81 new positions and closed 65 in Q2 2025.
  • Maverick Capital's portfolio value rose 18% quarter-over-quarter to $6.66B.

Based on Maverick Capital's 13F filing for Q2 2025, filed 14 Aug 2025.